PPIB and dengue disease: While there has been intensive research over many decades characterizing the anti-dengue immune response to various candidate dengue vaccines, there have only been a limited number of studies performed using interferon receptor knockout AG129 (interferon α/β, γ receptor knockout) or interferon α/β receptor knockout (INFAR1) mice.